E-Cigarette Perception for E-Cigarette Use

DR
Overseen ByDanielle R Davis, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores differences between men and women in their attraction to and potential addiction to menthol-flavored e-cigarettes, both with and without nicotine. Participants will try and rate e-cigarettes with varying nicotine levels and choose between them in separate lab sessions. This study suits current cigarette smokers who have tried e-cigarettes before and are not attempting to quit tobacco use. As an unphased trial, it offers participants the chance to contribute to important research on e-cigarette preferences and addiction.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it mentions that you can participate if you are using psychoactive drugs as long as they are prescribed and your use is stable.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that using e-cigarettes with nicotine carries risks. Studies have found that e-cigarettes contain nicotine, which is highly addictive and harmful to health. For instance, e-cigarettes with higher nicotine levels can impair the lungs' ability to clear harmful substances.

In this trial, it is important to note that products with more than 50 mg/mL of nicotine, such as the 59 mg/mL variant, can be particularly dangerous. Reports indicate that e-cigarettes with 36 mg/mL and 59 mg/mL nicotine levels can release substances that may harm lung health.

Overall, while e-cigarettes are popular, no amount of nicotine is completely safe. Higher nicotine levels, in particular, may pose even greater risks.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how people perceive e-cigarettes with different nicotine levels. Unlike traditional smoking cessation methods like nicotine patches or gums, this study examines the immediate preferences and choices when sampling e-cigarettes with 0mg/ml, 36mg/ml, and 59mg/ml nicotine levels. By understanding these preferences, the study could provide insights into how nicotine levels affect user choice, potentially leading to more tailored approaches in helping people quit smoking or switch to less harmful alternatives.

What evidence suggests that this trial's treatments could be effective for e-cigarette use?

Research has shown that e-cigarettes with a nicotine level of 36 mg/mL can reduce exposure to some harmful chemicals found in regular cigarettes, such as NNAL, even if users continue smoking traditional cigarettes. Other studies suggest that e-cigarettes with this nicotine level may be more beneficial than those with lower levels, especially for smokers trying to reduce their exposure to toxins. In this trial, participants will sample and rate e-cigarettes with varying nicotine levels, including 36 mg/mL, during the Sampling Session - Lab 1. For the 59 mg/mL nicotine level, studies indicate a higher intake of nicotine, which could lead to increased feelings of satisfaction or a stronger "nicotine hit" compared to lower levels. This concentration is particularly noted among young e-cigarette users. Participants will also make choices between e-cigarettes with different nicotine levels, including 59 mg/mL, during the Concurrent Choice Session - Lab 2. Overall, higher nicotine levels in e-cigarettes may influence their appeal and potential for addiction.678910

Who Is on the Research Team?

DR

Danielle R Davis, PhD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for English-reading individuals who currently smoke cigarettes, have used e-cigarettes before, and are not trying to quit tobacco. Participants must also have their cigarette use confirmed through biochemical tests.

Inclusion Criteria

I can read and write in English.
I currently smoke cigarettes.
I have used e-cigarettes before.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Sampling Session

Participants will sample and rate three menthol flavored e-cigarettes with varying levels of nicotine

1 day
1 visit (in-person)

Concurrent Choice Session

Participants will make choices between two menthol e-cigarettes with different levels of nicotine

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

2-4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Nicotine Level 1 (0mg/ml)
  • Nicotine Level 2 (36mg/ml)
  • Nicotine Level 3 (59mg/ml)

Trial Overview

The study is looking at how appealing and addictive menthol flavored e-cigarettes are by comparing three nicotine levels: none (0mg/ml), medium (36mg/ml), and high (59mg/ml) between male and female participants.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Sampling Session - Lab 1Experimental Treatment3 Interventions
Group II: Concurrent Choice Session- Lab 2Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Citations

1.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/33857436/

Effect of an electronic nicotine delivery system with 0, 8, or 36 ...

Use of an ENDS with cigarette-like nicotine delivery can reduce exposure to a major pulmonary carcinogen, NNAL, even with concurrent smoking.

Effect of an electronic nicotine delivery system with 0, 8, or ...

This study suggests that an ENDS with cigarette-like nicotine delivery might provide greater benefits than an ENDS with lower nicotine delivery for smokers ...

Effect of an electronic nicotine delivery system with 0, 8, or ...

Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure

A Pilot Study of E-Cigarette Naïve Cigarette Smokers and the ...

This experiment provides data demonstrating that e-cigarettes did not reduce craving or smoking severity in e-cigarette naïve users. However, since this was a ...

Influence of liquid nicotine concentration and user experience.

Electronic cigarette (ECIG) nicotine delivery and other effects may depend on liquid nicotine concentration and user experience.

Health Effects of Vaping | Smoking and Tobacco Use

No tobacco products, including e-cigarettes, are safe. Most e-cigarettes contain nicotine, which is highly addictive and is a health danger for ...

Biomarkers of Nicotine and Toxicant Exposure by E-liquid ...

E-cigarette users who reported use of products with nicotine levels of 5.0+% did not exhibit significantly higher nicotine metabolites than those using other ...

High Nicotine Content in Electronic Cigarettes Disrupts ...

High nicotine content in electronic cigarettes disrupts mucociliary clearance, the essential defense mechanism of the lung.

e-cigarette liquids: acute toxicity hazards and health risks

* The strength of nicotine salt in a vaping substance must not exceed 50 mg/mL. * The total nicotine content in a container of vaping substance sold at retail ...

Tobacco: E-cigarettes

Evidence reveals that these products are harmful to health and are not safe. However, it is too early to provide a clear answer on the long-term impact of using ...